openaccessgovernment11d
Personalized medicine in oncology: Small molecule inhibitors, biologics and immunotherapies
Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...
The EMBO Journal4d
A CRISPR-Cas9 screen reveals genetic determinants of the cellular response to decitabine
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
eLife2d
Bridging the Gap in Cancer Cell Behavior Against Matrix Stiffening: Insights from a Trizonal Model
Laboratory for Research on the Structure of Matter (LRSM), University of Pennsylvania, Philadelphia, United States ...
Armed robbery in Revesby3d
Dana-Farber Unveils Findings at 2025 ASCO GU Symposium
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
‘It’s All Gone’: Devastation, Survival, and Hope From the California Fires
IT’S EASY to shorthand Los Angeles as a dream factory, a place populated solely by movie stars, award shows, influencers, and ...
EurekAlert!3d
Dana-Farber researchers present findings at 2025 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
Frontiers14d
Combination Immune Therapies for the Treatment or Prevention of Breast or Gynecological Cancers
Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current strategies have targeted different ...
eLife16d
Cell-cycle and Age-Related Modulations of Mouse Chromosome Stiffness
Surprisingly, chromosomes from three meiosis-specific cohesin mutants exhibited stiffness ... our study underscores the dynamic and cyclical nature of chromosome stiffness, modulated by both the cell ...
PipelineReview.com9d
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
SHANGHAI, China I 5, 2025 I Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as ...
Frontiers11d
A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival
Cells were analyzed with a Becton-Dickinson FACSymphony™ flow cytometer. Cell cycle analyses were performed three times. MCF7, MDA-MB-231 and Rosi cells were treated with LB-100 and Compound 2 at 5–20 ...